Regencell Bioscience Holdings Ltd (RGC) stock
RGCNasdaqMedicinal Chemicals & Botanical Products
$4.55−0.17 (-3.60%)
Close on Nov 17, 2026Market cap $2.26BP/E –Yield –
Regencell Bioscience cash
Cash and short-term investments held at the end of each period.
Regencell Bioscience's cash was $14.19M at Jun 30, 2026. For fiscal 2026 it was $14.19M, up 189.8% from the year before. The highest annual figure on record is $16.42M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $14.19M | +189.8% |
| FY2025 | Jun 30, 2025 | $4.90M | -38.5% |
| FY2024 | Jun 30, 2024 | $7.96M | -31.2% |
| FY2023 | Jun 30, 2023 | $11.56M | -29.6% |
| FY2022 | Jun 30, 2022 | $16.42M | +27532.0% |
| FY2021 | Jun 30, 2021 | $59.41K | -84.6% |
| FY2020 | Jun 30, 2020 | $386.98K | +59.0% |
| FY2019 | Jun 30, 2019 | $243.31K | +58.7% |
| FY2018 | Jun 30, 2018 | $153.30K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $14.19M | +78.3% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $2.36M | -79.6% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $4.90M | -70.2% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $1.58M | +2553.0% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $7.96M | +1957.3% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $11.56M | +4653.2% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $16.42M | +10608.9% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $59.41K | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $386.98K | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $243.31K | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $153.30K | – |
See a number that looks wrong?